Skip to main content

AIGH Capital Management LLC

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 1835943 BALTIMORE, MD

Position in ZVRA

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$11,183,999
-$531,674 QoQ
Shares Held
1,200,000
-2.6% QoQ
Ownership
2.03%
of shares outstanding
% of Portfolio
2.29%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
6 quarters on record
Voting authority Sole 72.90008333333333.ToString("F0")% Shared 27.09991666666667.ToString("F0")% None 0.ToString("F0")%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Derivatives in ZVRA

reported options exposure · as of Sep 30, 2025
CallValue
$30,632,756
CallShares
3,221,110
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

AIGH Capital Management LLC holds $126,310,878 across 15 Biotechnology names. ZVRA ranks #6 (8.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 ZVRA
Zevra Therapeutics, Inc.
This page
1,200,000 $11,183,999

All Filings in ZVRA

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,183,999 1,200,000
2025-09-30 $11,715,673 1,231,932
2025-09-30 $30,632,756 3,221,110
2025-06-30 $8,095,446 918,893
2025-03-31 $10,771,435 1,438,109
2024-12-31 $6,577,039 788,614
2024-06-30 $890,197 181,673
2024-06-30 $674,240 137,600